Jerome Canady Research Institute
for Advanced Biological and Technological Sciences

2019


USMI and JCRI-ABTS Receive FDA Approval to Conduct the First U.S. Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Cancer

Jul 2019
Takoma Park, MD
Read Press Release

2018


US Medical Innovations to Present Canady Robotics SR-70™ Surgical System, the First Mini-Invasive Robotic Assisted Surgical System That Fits in the Palm of Your Hand, at the 2018 American College of Surgeons Clinical Congress

Oct 2018
Takoma Park, MD
Read Press Release

 

Jerome Canady, MD Invited Speaker: The Evolution of Plasma Energy ACS Session: Energy Sources in Surgery: How to Improve Efficacy Congresso Congiunto 2018 Society of Italian Surgeons

Oct 2018
Roma Convention Center La Nuvola Rom, Italy
October 14-18, 2018

US Patent Office Issues Decision to Grant Patent for USMI’s Cold Atmospheric Plasma for the Selective Ablation of Cancer Cells

Jul 2018
USMI announced today that the United States Patent Office (USPO) has issued USPI patent No. 10,023,858 B2, further expanding its intellectual patent property portfolio for the application of delivering Cold Atmospheric Plasma (CAP) technology to selectively target cancer cells. 

Takoma Park, MD

Read Press Release

 
US Patent Office Issues Patent for USMI’s Cold Atmospheric Plasma for the Treatment of Cancer

Jun 2018
USMI is the first company in the world to integrate a high frequency electrosurgical generator and plasma gas to deliver a Cold Atmospheric Plasma (CAP) for the selective treatment of cancer.

Read Press Release

2017


US Medical Innovations, LLC and the George Washington University Sign a $5.3 Million Agreement to Launch a New Plasma-Based Cancer Therapy Program

Sep 2017
Takoma Park, MD
Read Press Release

 
US Medical Innovations Announces Canady Helios Cold Plasma and Hybrid Plasma Scalpels Used in the First Clinical Liver Resection Performed to Remove and Selectively Kill Liver Cancer Tumor Cells.

June 2017
Takoma Park, MD
Read Full Article

 

Dr. Rowe and Dr. Cheng presented work at the 4th International Workshop on Plasma for Cancer Treatment (IWPCT-2017) at the Institut Curie in Paris, held on March 27–28 2017.

April 2017
“Effect of the Canady Helios Cold Plasma Scalpel on the Selective Elimination of Cancer”

 
JCRI, with US Medical Innovations, completed the third FDA Humanitarian Compassionate Use surgery with cold plasma.

January 2017

2016


Dr. Canady and Dr. Rowe presented work at the 3th International Workshop on Plasma for Cancer Treatment (IWPCT-2016) in Washington, D.C., held on April 11-12 2016

“Clinical Application of Cold Atmospheric Plasma (CAP) for Stage IV Colorectal Cancer (Peritoneal Carcinomatosis): Lessons Learned”

 

Chinese Patent Office Issues Decision to Grant Patent for USMI’s Canady Hybrid Plasma™ Technology

Feb 2016
Takoma Park, MD

Read Press Release

Japanese Patent Office Issues Decision to Grant Patent for USMI’s Canady Hybrid Plasma™ Technology

Feb 2016
Takoma Park, MD

Read Press Release

 
US Medical Innovations, LLC receives ISO 13485:2003 Certification following review of the Quality Management System for USMI, PMLS, Canady Robotics and Canady Biotechnology

Jan 2016
Takoma Park, MD

2015


Electric Discharge During Electrosurgery

July 14, 2015
Takoma Park, MD
Read Full Article

 
Cold Plasma Used In World’s First Clinical Surgical Procedure Performed To Selectively Kill Cancer Tumor Cells

April 2015
Takoma Park, MD
Read Full Article

IWPCT – Second International Workshop on Plasma for Cancer Treatment

Development and Clinical Application of Hybrid and Cold Atmospheric Plasma Combined with Systemic Chemotherapy and Selective 3D Conformal Radiation Therapy: A Novel Approach to the Treatment of Peritoneal Metastases from Colorectal Cancer
March 16-17
Jerome Canady, M.D.
Invited Guest Speaker
Nagoya University
Nagoya Japan

 
Jerome Canady Research Institute receives ISO-9001: 2008 Certification

January 2015
Takoma Park, MD
Read the Article

Expertise.  Ingenuity.  Affordability.